Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guhong injection for ischemic stroke
ChiCTR2300078431Phase 4Recruiting
- Sponsor
- Peking University First Hospital
- Start
- May 2023
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Guhong Injection in ischemic stroke (2 arms), sponsored by Peking University First Hospital. Primary endpoint: modified Rankin Scale score. Started May 2023; status: recruiting.
02
Drugs
Guhong Injection
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2300078431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078431.